Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Blackstone closes first life-science fund at $4.6bn

Friday, July 10, 2020

Laxman Pai, Opalesque Asia:

Blackstone Group closed its inaugural life sciences fund, Blackstone Life Sciences V (BXLS V), at its hard cap of $4.6 billion, making it the largest life sciences private fund raised till date.

Blackstone Life Sciences (BLS) invests in established life science companies, finances late-stage products, and makes growth investments in emerging life-science companies.

The unit has already invested about $1 billion from the fund over the past three months with bets on drugs that target high cholesterol, kidney disease in children and devices for diabetes patients, according to a filing Thursday by the New York-based company.

Blackstone Group launched BLS in 2018 after it acquired Clarus, a life-sciences private equity manager, which had raised $2.6 billion since its founding in 2005. Its final fund before the acquisition by Blackstone was Clarus IV, which closed at $910 million in 2017.

Nicholas Galakatos, Ph.D., Global Head of Blackstone Life Sciences, said, "Our mission to bring innovative medicines to patients by drawing on our domain expertise and scale capital has resonated with investors. With many more promising products in the life sciences industry's pipeline than capital available to advance them, we look forward to continuing to bring new treatment options and innovations to the patients who need them."

Investors include the California State Teachers' Retirement System, West Sacramento; Texas Teacher Retirement S......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1